UK Lays Out Reduced-Data Pathway For Biosimilars
Creates Opportunity For Country To Be First Launch Market, Industry Says
• By David Wallace
The MHRA is planning to reduce the data burden for applicants seeking biosimilar approval • Source: Shutterstock